Illness	Number of cases
Non-follicular lymphoma (C83.3)	235
Myeloid leukaemia - Acute myeloblastic leukemia not having achieved remission (C92.00)	207
Multiple myeloma and malignant plasma cell neoplasms - Multiple myeloma not having achieved remission (C90.00)	140
Non-follicular lymphoma (C83.1)	41
Donors of organs and tissues (Z52.01)	34
Follicular lymphoma (C82.1)	32
Malignant neoplasm without specification of site - Disseminated malignant neoplasm unspecified (C80.0)	27
Follicular lymphoma (C82.3)	21
Non-follicular lymphoma (C83.0)	20
Other neoplasms of uncertain or unknown behaviour of lymphoid haematopoietic and related tissue - Osteomyelofibrosis (D47.4)	19

Top 10 treatments

Treatment	Number
Others therapeutic procedures to influence the immune system (8-547.0)	354
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	253
Radiotherapy with high-energy beams for cancer - high voltage radiotherapy (8-522.91)	213
(9-984.7)	199
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11)	187
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.51)	136
(9-984.8)	136
Computed tomography (CT) of the chest without contrast medium (3-202)	135
Computer assisted visualisation of body structures in 3 dimensions - virtual 3D reconstruction technique (3-994)	133
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.21)	126

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0105

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ02
CQ03	über Tumorboard
CQ05	Weiterführende standortbezogene Informationen unter: www.perinatalzentren.org
CQ25
CQ04

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
313	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
218	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
209	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities	Lehre und Lehrauftrag der HMU Erfurt, an den Universitäten Jena, München, Frankfurt, Freiburg, Regensburg, Greifswald, Technische Universität Ilmenau
Lectureships / teaching posts at universities of applied sciences	Mentorenprojekt der LÄK Thüringen, EANS-Observership-Programm (mit internationalen Fachärzten und AiW)
Project-related cooperation with colleges and universities	u.a.Uni Jena, Uni Leipzig, IMTEK Freiburg, Neurochirurgie Uni Freiburg, HNO Uni Saarbrücken, Psychologie Uni Giessen, Neurofibromatoseambulanz Uni Hamburg
Participation in multi-centre Phase I/II studies	u.a. ADRISK: Multicenter randomized Phase II study within the German interdisciplinary study group of German Cancer Society (IAG KHT) IMSTAR HN: Multicenter randomized controlled phase III study.
Participation in multi-centre phase III/IV studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies	Uni Jena, Uni Leipzig
Student training (clinical traineeship / internship year)
Editors of scientific journals/textbooks	u.a. Lehrbuch Biomedizinische Technik, Band XI: Neurotechnik
Doctoral supervision	Universitätsmedizin Jena, Greifswald